Earnings before interest, taxes, depreciation and amortization (EBITDA) fell 24 per cent to a loss of $6.2 million. Read more: Valens stock to list on Nasdaq Thursday Read more: Valens posts nearly $25M in Q3 revenue, continues aggressive acquisition strategy And net loss rose 47 per cent to a loss of $12.8 million. Valens has made a number of acquisitions this year, including buying extractor Verse for an undisclosed amount and Citizen Stash Cannabis Corp. (TSXV: CSC) (OTCQB: EXPFF) (FRANKFURT: MB31) in an all-stock transaction valued at around $54.3 million.